Loading...
miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel
Breast cancer remains the most commonly diagnosed cancer in Chinese women. Paclitaxel (PTX) is a chemotherapy medication used to treat breast cancer patients. However, a side effect of paclitaxel is the severe drug resistance. Previous studies demonstrated that dysregulation of microRNAs could regul...
Na minha lista:
| Udgivet i: | Open Med (Wars) |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
De Gruyter
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555243/ https://ncbi.nlm.nih.gov/pubmed/31206033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2019-0049 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|